speb/financial-data huggingface dataset:
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Net Other Financing Charges: 397400000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Net PPE: 19111100000.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: 800000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 11460400000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Revenue: 400200000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 709700000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 147300000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 1357400000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 641700000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Normalized Income: -390490000.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 2370500000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Operating Income: -62000000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Operating Revenue: 20715100000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 102388120.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 14600000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 7700000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 11359700000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 1700000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Other Inventories: 37400000.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 288300000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 1254200000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: 400200000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 6000000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 1328600000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Other Payable: 1457400000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Other Properties: 1402200000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 23300000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 431000000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Other Special Charges: -3700000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Payables: 6643000000.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Pension And Employee Benefit Expense: 33700000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 24400000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 597900000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Pretax Income: -345500000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: -5000000.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Purchase Of Business: 0.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: -395100000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 1764000000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 16849900000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 632000000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 37000000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 37000000.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: -4959100000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Research And Development: 24700000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 1875400000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 8148600000.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 31300000.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 800000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 1033800000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 1205700000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Share Issued: 102388120.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Special Income Charges: 3700000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 11462100000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 11460400000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 1110000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Tax Provision: 42400000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.30
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 116900000.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -78400000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Total Assets: 33202700000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 19587400000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Total Debt: 12517300000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 11462100000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Total Expenses: 20777100000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 21740600000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 21864300000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 11452100000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 58200000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 8900000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 3700000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 3700000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Work In Process: 213900000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Working Capital: 1049900000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 5010800000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 1995000000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 2206500000.00
TIRUMALCHM.NS income_statement (quarterly, 2024-09-30) — Basic Average Shares: 101875000.00
TIRUMALCHM.NS income_statement (quarterly, 2024-09-30) — Basic EPS: 0.48
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 805000000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 102400000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 2373300000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 4203800000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 102400000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 12096300000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 13097900000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 10443700000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 45400000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 3521300000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 3566700000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 9731100000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 26100000.00
TIRUMALCHM.NS income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 101875000.00
TIRUMALCHM.NS income_statement (quarterly, 2024-09-30) — Diluted EPS: 0.48
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 1900000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 21654900000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 2726000000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 25129700000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 2206500000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 759600000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 9512100000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 10271700000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 159100000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 10660100000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 21654900000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 12094400000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 751700000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 102388120.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 1413500000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 88400000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 11993900000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 340000000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 402200000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 8557000000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 1830500000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Payables: 5095500000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 102388120.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 12096300000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 12094400000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Taxes Receivable: 105400000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 34685700000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 21608400000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 13838400000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 12096300000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 22589400000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 24242000000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 12858300000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 84700000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 712600000.00
TIRUMALCHM.NS income_statement (quarterly, 2024-12-31) — +Operating Expense: 1205500000.00
TIRUMALCHM.NS income_statement (quarterly, 2024-12-31) — +Total Revenue: 4466500000.00
TIRUMALCHM.NS income_statement (quarterly, 2024-12-31) — Basic Average Shares: 102487805.00
TIRUMALCHM.NS income_statement (quarterly, 2024-12-31) — Basic EPS: -4.10
TIRUMALCHM.NS income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 3618600000.00
TIRUMALCHM.NS income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 155400000.00
TIRUMALCHM.NS income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 155400000.00
TIRUMALCHM.NS income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 102487805.00
TIRUMALCHM.NS income_statement (quarterly, 2024-12-31) — Diluted EPS: -4.10
TIRUMALCHM.NS income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: -420200000.00
TIRUMALCHM.NS income_statement (quarterly, 2024-12-31) — EBIT: -355600000.00
TIRUMALCHM.NS income_statement (quarterly, 2024-12-31) — EBITDA: -200200000.00
TIRUMALCHM.NS income_statement (quarterly, 2024-12-31) — Gross Profit: 847900000.00
TIRUMALCHM.NS income_statement (quarterly, 2024-12-31) — Interest Expense: 143500000.00
TIRUMALCHM.NS income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 143500000.00
TIRUMALCHM.NS income_statement (quarterly, 2024-12-31) — Net Income: -420200000.00
TIRUMALCHM.NS income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: -420200000.00
TIRUMALCHM.NS income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: -420200000.00
TIRUMALCHM.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -420200000.00
TIRUMALCHM.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -420200000.00
TIRUMALCHM.NS income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: -420200000.00
TIRUMALCHM.NS income_statement (quarterly, 2024-12-31) — Net Interest Income: -143500000.00
TIRUMALCHM.NS income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -143500000.00
TIRUMALCHM.NS income_statement (quarterly, 2024-12-31) — Normalized EBITDA: -200200000.00
TIRUMALCHM.NS income_statement (quarterly, 2024-12-31) — Normalized Income: -420200000.00
TIRUMALCHM.NS income_statement (quarterly, 2024-12-31) — Operating Income: -357600000.00
TIRUMALCHM.NS income_statement (quarterly, 2024-12-31) — Operating Revenue: 4466500000.00
TIRUMALCHM.NS income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 2000000.00
TIRUMALCHM.NS income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 796600000.00
TIRUMALCHM.NS income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
TIRUMALCHM.NS income_statement (quarterly, 2024-12-31) — Pretax Income: -499100000.00
TIRUMALCHM.NS income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 3618600000.00
TIRUMALCHM.NS income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 155400000.00
TIRUMALCHM.NS income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
TIRUMALCHM.NS income_statement (quarterly, 2024-12-31) — Tax Provision: -78900000.00
TIRUMALCHM.NS income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.16
TIRUMALCHM.NS income_statement (quarterly, 2024-12-31) — Total Expenses: 4824100000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — +Operating Expense: 4343500000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 1328700000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — +Total Revenue: 20369900000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 5230600000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 4484300000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 4484300000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 1989900000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 1989900000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -3697800000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -3697800000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 197100000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 197100000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -101200000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -101200000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Amortization: 1300000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 1300000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 1996000000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 1996000000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 102388120.00
TIRUMALCHM.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 102627737.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Basic EPS: -4.50
TIRUMALCHM.NS income_statement (quarterly, 2025-03-31) — Basic EPS: -1.37
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 4056000000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 1516500000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 1516500000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -6129000000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Capital Expenditure Reported: -6129000000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 790500000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 790500000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 102400000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 102400000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 1829100000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 1829100000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1856300000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1856300000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -102400000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 53900000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 53900000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 1775200000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 1775200000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Change In Inventory: 45000000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -44100000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: 485800000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Change In Payable: -1238200000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -141900000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -900900000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Changes In Cash: -2333300000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Common Stock: 102400000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 102400000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 11556700000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 11556700000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Common Stock Issuance: 0.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 13521100000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 13521100000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 16067500000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 3937100000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Current Assets: 9610100000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 9610100000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 50800000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 50800000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Current Debt: 3059200000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 3059200000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 3110000000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 3110000000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 9259700000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 9259700000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 49300000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 49300000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Depreciation: 611000000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 611000000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 611000000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 183500000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 609700000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 183500000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 102388120.00
TIRUMALCHM.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 102627737.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Diluted EPS: -4.50
TIRUMALCHM.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: -1.37
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: -461000000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -140600000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 11700000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 11700000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Dividends Received Cfi: 21000000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — EBIT: 36300000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-03-31) — EBIT: 42600000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — EBITDA: 647300000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-03-31) — EBITDA: 226100000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: 106400000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — End Cash Position: 1829100000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Financial Assets: 29400000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Financial Assets: 29400000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: 3746200000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 502900000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 502900000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: -6787800000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: 25400000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: -14900000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 198800000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 1400000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 1400000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 2091100000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 2091100000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 29732200000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 29732200000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Gross Profit: 4302400000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 1293500000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Hedging Assets Current: 9100000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Hedging Assets Current: 9100000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Interest Expense: 444800000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 152700000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 444800000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 152700000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Interest Income: 77200000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 77200000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -1325500000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 78800000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Inventories Adjustments Allowances: -11100000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Inventories Adjustments Allowances: -11100000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Inventory: 2472700000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 2472700000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 28622500000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 28622500000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -5420700000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 1996000000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 1996000000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 0.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 13927200000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 726800000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 726800000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 739700000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 739700000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 14006600000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 14006600000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 14746300000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 14746300000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 13927200000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -8739900000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 138400000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 138400000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 12639200000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 12639200000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Net Business Purchase And Sale: 0.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 0.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Net Debt: 15236700000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 15236700000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -152300000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Net Income: -461000000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-03-31) — Net Income: -140600000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: -461000000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -140600000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: -461000000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -140600000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -461000000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -140600000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -461000000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -140600000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: -408500000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: -461000000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -140600000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Net Interest Income: -414300000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -152700000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: 344000000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 5187300000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: 5187300000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -414300000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -152700000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: 241600000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Net PPE: 26034400000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 26034400000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: 22900000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 11555300000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 11555300000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Revenue: 410800000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 410800000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 640100000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 640100000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 138400000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 138400000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 396100000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 396100000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 658400000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 226100000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Normalized Income: -453230000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-03-31) — Normalized Income: -140600000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: -658800000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Operating Income: -41100000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-03-31) — Operating Income: -35200000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Operating Revenue: 20369900000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 5230600000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 102388120.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 102388120.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 1397200000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 1397200000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 8800000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 8800000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 11454300000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 11454300000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 1400000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 1400000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Other Inventories: 36800000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Other Inventories: 36800000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 393400000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 100000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 100000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: 410800000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 410800000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 9400000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 77800000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 1590600000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 933900000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Other Payable: 1496200000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 1496200000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Other Properties: 1328600000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 1328600000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 17000000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 17000000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 27200000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 27200000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Other Special Charges: -38600000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
TIRUMALCHM.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Payables: 5992200000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Payables: 5992200000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Pension And Employee Benefit Expense: 38100000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 49300000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 49300000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 1520700000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 1520700000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Pretax Income: -408500000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-03-31) — Pretax Income: -110100000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: -32200000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Purchase Of Business: 0.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: 0.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 1612600000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 1612600000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 16067500000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 3937100000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 611000000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 183500000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 73800000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 73800000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -8739900000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Research And Development: 19100000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 1744400000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 1744400000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 7585800000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 7585800000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 344000000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 22900000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 1073100000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 1271900000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Share Issued: 102388120.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 102388120.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Special Income Charges: 38600000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 11556700000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 11556700000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 11555300000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 11555300000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: -3330000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Tax Provision: 52500000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 30500000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.30
TIRUMALCHM.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.30
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 107000000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 107000000.00
TIRUMALCHM.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -217900000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Total Assets: 38067500000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 38067500000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 25563300000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 25563300000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Total Debt: 17856300000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 17856300000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 11556700000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 11556700000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Total Expenses: 20411000000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 5265800000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 26510800000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 26510800000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 28457400000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 28457400000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 17251100000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 17251100000.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 46700000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 0.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 0.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Total Unusual Items: -11100000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
TIRUMALCHM.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: -11100000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Work In Process: 331500000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 331500000.00
TIRUMALCHM.NS balance_sheet (annual, 2025-03-31) — Working Capital: 350400000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 350400000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 1319200000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 4500500000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 102320819.00
TIRUMALCHM.NS income_statement (quarterly, 2025-06-30) — Basic EPS: -5.86
TIRUMALCHM.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 3665100000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 216400000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 216400000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 102320819.00
TIRUMALCHM.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: -5.86
TIRUMALCHM.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -599600000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-06-30) — EBIT: -461800000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-06-30) — EBITDA: -245400000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 835400000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 181900000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 181900000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-06-30) — Net Income: -599600000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -599600000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -599600000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -599600000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -599600000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -599600000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -181900000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -181900000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -245400000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-06-30) — Normalized Income: -599600000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-06-30) — Operating Income: -483800000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 4500500000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 22000000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 859700000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
TIRUMALCHM.NS income_statement (quarterly, 2025-06-30) — Pretax Income: -643700000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 3665100000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 216400000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
TIRUMALCHM.NS income_statement (quarterly, 2025-06-30) — Tax Provision: -44100000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.07
TIRUMALCHM.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 4984300000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 1303200000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 4453700000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 3770300000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 2047800000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 2027800000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 108729642.00
TIRUMALCHM.NS income_statement (quarterly, 2025-09-30) — Basic EPS: -3.07
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 815500000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 118700000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 1957000000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 3774700000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 118700000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 15324000000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 17398300000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 3414900000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 10937500000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 61600000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 4483600000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 4545200000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 9380300000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 55300000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 227900000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 227900000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 108729642.00
TIRUMALCHM.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: -3.07
TIRUMALCHM.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -333800000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-09-30) — EBIT: -180500000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-09-30) — EBITDA: 47400000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 900000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 30205700000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 1038800000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 257200000.00
TIRUMALCHM.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 257200000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 3592000000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 35364700000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 2027800000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 753900000.00
TIRUMALCHM.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 15557100000.00